Quest Diagnostics Inc. Stock Slides 4.1%, Underperforms Peers
Dow Jones2026/09/22 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Quest Diagnostics Inc. slipped 4.1% to $234.76 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average falling 0.4% to 51,863.69.
This was the stock's third consecutive day of losses.
Quest Diagnostics Inc. closed 5.7% below its 52-week high of $248.84, which the company reached on September 21st.
The stock underperformed when compared to some of its peers, as UnitedHealth Group Inc. fell 1.2% to $372.95, IQVIA Holdings Inc. rose 0.1% to $270.09, and Centene Corp. fell 2.60% to $63.30.
Trading volume totaled 2.7 million, compared to the 50-day average of 1.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 22, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Novo Nordisk (NVO.US) considers entering the hair loss market, seeking new growth points with its "post-Wegovy" strategy
Novo Nordisk is targeting the hair loss market, seeking to diversify its drug portfolio.
The growth of the traditional network equipment industry may have peaked! Piper Sandler lowers Cisco (CSCO.US) target price to 125 USD.
Piper Sandler analyst James Fish maintains a "Neutral" rating on Cisco, while lowering the target price from $132 to $125.
Runway Growth Finance director Edward J. Goldthorpe acquires USD 67,253.48 in common shares
Crypto prices
More
